DOW JONES21,917.16-410.32 -1.84%
S&P 5002,584.59-42.06 -1.60%
NASDAQ7,700.10-74.05 -0.95%
 News
Investors Who Bought Outlook Therapeutics (NASDAQ:OTLK) Shares Three Years Ago Are Now Down 98%
Simply Wall St. · 03/19 14:32
Outlook Therapeutics Announces LYTENAVA (bevacizumab-vikg), Anticipated Brand Name for ONS-5010, If Approved
GlobeNewswire · 03/05 13:00
Outlook Therapeutics Announces Closing of $10.2 Million Financings Priced At-The-Market
GlobeNewswire · 02/26 19:26
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Outlook Therapeutics, Inc.-OTLK
ACCESSWIRE · 02/25 14:15
Outlook Therapeutics Conducts $10.2M Offering at $1.016/Share
Benzinga · 02/24 13:14
Outlook Therapeutics Announces $10.2M Financings Priced At-The-Market
Benzinga · 02/24 13:08
Outlook Therapeutics Announces $10.2 Million Financings Priced At-The-Market
GlobeNewswire · 02/24 13:00
INVESTOR ALERT: Fields Kupka & Shukurov LLP Is Investigating Outlook Therapeutics, Inc. for Potential Securities Violations and Breach of Fiduciary Duty Claims.
GlobeNewswire · 02/18 18:28
Outlook Therapeutics EPS misses by $0.07
seekingalpha · 02/14 18:17
Outlook Therapeutics Q1 EPS $(0.62) Up From $(1) YoY
Benzinga · 02/14 13:03
Outlook Therapeutics Provides Business Update and Reports Financial Results for the First Quarter of Fiscal Year 2020
GlobeNewswire · 02/14 13:00
Outlook Therapeutics to Present at the 2020 BIO CEO & Investor Conference
GlobeNewswire · 02/04 13:00
Outlook Therapeutics streamlines capital structure; shares down 6% premarket
Seeking Alpha - Article · 01/28 13:47
Outlook Therapeutics Announces Agreements To 'Streamline' Capital Structure And Regain 100% Ownership Of Any Future Net Profits For ONS-5010
Benzinga · 01/28 13:02
TRNX, SVRA, PACD and EDSA among midday movers
Seeking Alpha - Article · 01/06 17:36
Outlook completes warrant restructuring
Seeking Alpha - Article · 12/26/2019 13:17
Outlook Therapeutics Announces Completion of Warrant Restructuring
GlobeNewswire · 12/26/2019 13:00
The Daily Biotech Pulse: NewLink Genetics Licenses Ovarian Cancer Dug, Correvio Awaits FDA Verdict
Benzinga · 12/24/2019 12:24
The Daily Biotech Pulse: NewLink Genetics Licenses Ovarian Cancer Dug, Correvio Awaits FDA Verdict
Benzinga · 12/24/2019 12:24
SDRL, ITCI, IDRA and OTLK among midday movers
Seeking Alpha - Article · 12/23/2019 17:37